Tolbutamide stimulates postnatal neogenesis of the islets of Langerhans as demonstrated by enumeration of the islets, in vivo studies and radioautography. This drug first causes transient dilatation of insular vessels and rapid blood flow, followed by de granulation of the beta cells. Reappearance of granules, proliferation of the small pancreatic ducts, formation of new islets and an increased number of small islets occur during chronic administration of tolbutamide. The implications of these findings for the management of juvenile diabetes are discussed.
Skip Nav Destination
Original contribution| August 01 1966
Effect of Tolbutamide on Postnatal Neogenesis of the Islet of Langerhans in Mouse
Srichitra C Bunnag, MD, PhD;
Nancy E Warner, MD;
Srichitra C Bunnag, Nancy E Warner, Sirotma Bunnag; Effect of Tolbutamide on Postnatal Neogenesis of the Islet of Langerhans in Mouse. Diabetes 1 August 1966; 15 (8): 597–603. https://doi.org/10.2337/diab.15.8.597
Download citation file: